External validation of the SYNTAX score II 2020 in patients with chronic renal insufficiency

Mengyao Li,Xu Liu,Mao Jiang,Yumeng Lei,Wenjie Liu,Zhongpei Li,Shicheng Li,Ruijie Liu,Xufen Cao,Liqiu Yan
DOI: https://doi.org/10.1002/ccd.30952
IF: 2.3
2024-01-12
Catheterization and Cardiovascular Interventions
Abstract:Background The SYNTAX score II 2020 (SSII‐2020) was created as a customized decision‐making tool for individuals diagnosed with complex coronary artery disease (CAD). Nevertheless, there has been a scarcity of research investigating the long‐term predictive significance of SSII‐2020 for patients with both CAD and chronic renal insufficiency (CRI) who undergo percutaneous coronary intervention (PCI). Aims We sought to showcase the prognostic capacity of SSII‐2020 in evaluating long‐term all‐cause mortality (ACM) within this high‐risk patient cohort. Methods A retrospective cohort comprising 1156 individuals diagnosed with CRI and exhibiting left main CAD, three‐vessel CAD or both was included in this investigation. We categorized participants into three groups based on the optimal SSII‐2020 threshold for predicting long‐term ACM, determined using the X‐tile software. Results At the median follow‐up duration of 6.3 years, the ACM rates were determined to be 10% in the low, 17% in the moderate, and 28% in the high SSII‐2020 groups (p
cardiac & cardiovascular systems
What problem does this paper attempt to address?